CPIX logo

CPIX
Cumberland Pharmaceuticals Inc.

2,659
Mkt Cap
$81.96M
Volume
190,960.00
52W High
$6.27
52W Low
$1.85
PE Ratio
-11.08
CPIX Fundamentals
Price
$5.12
Prev Close
$5.47
Open
$5.35
50D MA
$3.58
Beta
0.69
Avg. Volume
2.68M
EPS (Annual)
-$0.1909
P/B
3.79
Rev/Employee
$478,725.07
$57.52
Loading...
Loading...
News
all
press releases
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan
CPIX posts a wider y//y loss in Q1, as it unveils a $100-million Apotex deal and sharpens focus on orphan drug development.
Zacks·12d ago
News Placeholder
More News
News Placeholder
Cumberland Pharmaceuticals (NASDAQ:CPIX) Issues Earnings Results
Cumberland Pharmaceuticals (NASDAQ:CPIX - Get Free Report) posted its earnings results on Tuesday. The specialty pharmaceutical company reported ($0.13) earnings per share for the quarter, hitting...
MarketBeat·13d ago
News Placeholder
Cumberland Pharmaceuticals Q1 Earnings Call Highlights
Cumberland Pharmaceuticals (NASDAQ:CPIX) executives highlighted a planned strategic transaction with Apotex, updates across several marketed brands, and progress in the company's late-stage pipeline...
MarketBeat·13d ago
News Placeholder
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE PR Newswire NASHVILLE, Tenn., May 5, 2026...
PR Newswire·13d ago
News Placeholder
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease RedHill's RHB-204 Demonstrates Comparable MAP Killing...
PR Newswire·18d ago
News Placeholder
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE PR Newswire NASHVILLE, Tenn., April...
PR Newswire·20d ago
News Placeholder
Cumberland Pharmaceuticals (CPIX) Expected to Announce Earnings on Tuesday
Cumberland Pharmaceuticals (NASDAQ:CPIX) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 5. (View Earnings Report at...
MarketBeat·20d ago
News Placeholder
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights PR Newswire TEL AVIV...
PR Newswire·21d ago
News Placeholder
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving Average - Here's What Happened
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving Average - What's Next...
MarketBeat·24d ago
News Placeholder
Dow Falls Over 200 Points; Tesla Shares Slip After Q1 Results
Dow Jones drops 0.44%, NASDAQ falls 0.31%, S&P 500 down 0.22%. Tesla shares drop 1% after reporting earnings. Auddia Inc. and Cumberland Pharmaceuticals Inc. see significant gains.read more...
Benzinga·25d ago
<
1
2
...
>

Latest CPIX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.